vimarsana.com

துணை ப்ரெஸிடெஂட் ரொபெர்டோ லாகொர்த்தே News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Let s Talk about Long-COVID (Chronic COVID Syndrome)

Let s Talk about Long-COVID (Chronic COVID Syndrome) insights from industryGermano TarantinoScientific DirectorPharmaNutra S.p.A In this interview, Germano Tarantino, the Scientific Director at PharmaNutra S.p.A, talks to NewsMed about long-COVID (also known as chronic COVID syndrome). To begin, can you tell us a bit about chronic COVID syndrome (also known as Long-COVID) and some of its symptoms? Long-COVID is a syndrome characterized by long-term SARS-CoV-2 infection symptoms persistent at least 4 weeks from the onset of symptoms. In fact, even if most people affected by COVID-19 recover completely within a few weeks, some other, continue to experience symptoms after many weeks or months

The American FDA Awards The Cetylated Esters Patented By PharmaNutra Gras Substance Recognition

Press release content from PR Newswire. The AP news staff was not involved in its creation. The American FDA Awards The Cetylated Esters Patented By PharmaNutra Gras Substance Recognition December 23, 2020 GMT PharmaNutra Logo PISA, Italy, Dec. 23, 2020 /PRNewswire/ PharmaNutra S.p.A. (the “Company”), specialised in iron-based nutritional supplements and in medical devices for muscles and joints, communicates that its patented Cetylated Esters (CFA) has been recognized as GRAS (acronym for Generally Recognized As Safe)for the U.S. market. Germano Tarantino, Scientific Director of PharmaNutra S.p.A. comments: “At the request of Pharmanutra, a panel of independent scientists (“the GRAS Panel”), qualified by their relevant national and international experience and scientific training to evaluate the safety of food-ingredients, conducted a critical and comprehensive evaluation of the available pertinent data and information concerning the use of Pharmanutra’s CFA as a

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.